Terazosin study for early Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests if the blood pressure drug terazosin can help slow down Parkinson's disease. It is for people recently diagnosed (within 3 years) who are not yet on many Parkinson's medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have been diagnosed with Parkinson's disease within the last 3 years.
- You are not taking more than 2 Parkinson's medications.
- Your Parkinson's symptoms are mild to moderate (Hoehn and Yahr stage 0-2).
- You do not have a history of liver problems, anemia, or low blood pressure when standing up.
- You are not currently taking terazosin or similar drugs (like prazosin or tamsulosin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This trial tests whether the drug cilostazol can help people with Parkinson's disease who have involuntary movements (dyskinesia) caused by their levodopa treatment. You may join if you have had Parkinson's for at least 5 years, take stable doses of levodopa/carbidopa, and have dyskinesia.
This trial tests whether terazosin, a drug for blood pressure and enlarged prostate, can improve energy use in brain cells affected by Parkinson's. If it works, it might slow disease progression.
This early-stage study tests whether the blood-pressure medicine terazosin can improve thinking and behavior in people with dementia with Lewy bodies. If you qualify, you would stay on your current dementia medicines for at least a few weeks so researchers can better see terazosin’s effect.
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.